Skip to main content
FENC logo

Fennec Pharmaceuticals Inc.

FENCNASDAQHealthcareBiotechnology

$10.62Today:- (-)1Y +15.18%

As of Oct 27, 2026 close

Market cap
$386.89M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$5.65$13.25
Volume (live)
-
Avg. volume (3M)
122.90K

Fennec Pharmaceuticals (FENC) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Fennec Pharmaceuticals had return on equity of -65.8%, a current ratio of 6.37 (down from 6.38) and return on assets of -6.8% (down from 4.5%). A current ratio of 6.37 means current assets exceed current liabilities.

Fennec Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2015FY 2014FY 2006FY 2005
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2015Dec 2014Dec 2006Dec 2005
Valuation Ratios
Forward P/E15.8837.3690.856.326.328.87----
P/S Ratio5.893.6514.25164.24-1131.07----
P/B Ratio7.41-29.57-26.06-98.137.256.61----
Price/Tangible Book7.41---7.256.61----
Price/OCF-6.43--------
Enterprise Value Ratios
EV/Revenue5.833.4814.88160.94-935.98----
EV/EBITDA-45.94--------
EV/EBIT-64.41--------
Profitability & Returns
Return on Equity (ROE)-65.82%---359.22%-77.36%-88.45%-215.01%-354.98%--
Return on Assets (ROA)-6.80%4.47%-29.67%-57.21%-39.99%-49.07%-159.36%-121.29%--
Return on Invested Capital (ROIC)-------5815.38%-4426.15%--
Return on Capital Employed (ROCE)-10.50%6.80%-66.10%-101.20%-83.00%-61.50%-195.65%-148.91%--
Leverage & Solvency Ratios
Debt/Equity--3.29-2.66-9.690.32--0.00--
Debt/EBITDA-5.37--------
Liquidity Ratios
Current Ratio6.376.383.565.8013.5413.39-5.39--
Quick Ratio5.715.712.925.4912.7612.93-5.24--
Efficiency Ratios
Asset Turnover0.771.320.790.06-0.010.000.00--
Inventory Turnover2.871.980.92-------
Yield & Distribution Ratios
Earnings Yield-3.70%-0.25%-5.30%-9.41%-15.16%-9.42%----
Buyback Yield-4.70%-2.71%-1.14%-1.03%-9.71%-19.14%-11.04%---
Total Return-------11.04%---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Fennec Pharmaceuticals Financial Ratios

What is Fennec Pharmaceuticals's return on equity?

Fennec Pharmaceuticals's return on equity (ROE) was -65.8% for fiscal 2025 (period ended Dec 31, 2025).

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition